Tell us about your search experience on the TGA website - complete our short survey
Notice for tozinameran (Pfizer Australia Pty Ltd)
Active ingredients
tozinameran
Sponsor
Date of review outcome
Lapse date
Type
Provisional determination
Indication
Active immunisation against COVID-19 disease caused by SARS-CoV-2 virus in individuals aged 6 months to <5 years.
Therapeutic area
Infectious diseases